News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
FARRELL STEPHEN C
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Granted 715 shares
@ $40.18, valued at
$28.7k
|
|
| 06/16/2023 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Exercised 1,709 shares
@ $0
Exercised 3,127 options
@ $52.67, valued at
$164.7k
|
|
| 10/12/2022 |
4
| FARRELL STEPHEN C (CEO) has filed a Form 4 on Convey Health Solutions Holdings, Inc.|
Txns:
| Disposed/sold 163,373 shares
@ $10.5, valued at
$1.7M
Disposed/sold 525,434 options to buy
@ $7.94, valued at
$4.2M
Disposed/sold 975,806 options to buy
@ $0
Disposed/sold 355,561 options to buy
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2022 |
4
| FARRELL STEPHEN C (CEO) has filed a Form 4 on Convey Health Solutions Holdings, Inc.|
Txns:
| Granted 355,561 restricted stock units
@ $0 |
|
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 40,000 options to buy
@ $1.03, valued at
$41.2k
|
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2018 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 40,000 options to buy
@ $2.06, valued at
$82.4k
|
|
| 06/18/2018 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Granted 3,691 shares
@ $0 |
|
| 03/19/2018 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Granted 1,206 options to buy
@ $16.15, valued at
$19.5k
|
|
| 07/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/10/2016 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Granted 10,000 options
@ $8.35, valued at
$83.5k
|
|
| 07/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/27/2016 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Granted 20,000 options
@ $5.54, valued at
$110.8k
|
|
| 01/05/2016 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on STAAR SURGICAL CO|
Txns:
| Granted 10,328 options
@ $7.14, valued at
$73.7k
|
|
| 11/10/2015 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Bought 50,000 shares
@ $3.83, valued at
$191.5k
|
|
| 07/06/2015 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 20,000 options to buy
@ $3.57, valued at
$71.4k
|
|
| 10/10/2014 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Bought 32,050 shares
@ $3.12, valued at
$100k
|
|
| 08/18/2014 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Disposed/sold 11,683 shares
@ $0
Disposed/sold 32,500 options to buy
@ $5.77, valued at
$187.5k
Disposed/sold 32,500 options to buy
@ $9.31, valued at
$302.6k
Disposed/sold 15,000 options to buy
@ $4.75, valued at
$71.3k
Disposed/sold 17,500 options to buy
@ $14.73, valued at
$257.8k
Disposed/sold 15,000 options to buy
@ $14.73, valued at
$221k
Disposed/sold 15,214 options to buy
@ $40.37, valued at
$614.2k
Disposed/sold 9,203 options to buy
@ $34.86, valued at
$320.8k
|
|
| 07/03/2014 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 20,000 options to buy
@ $3.11, valued at
$62.2k
|
|
| 06/04/2014 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Sold 3,750 shares
@ $89.9396, valued at
$337.3k
|
|
| 04/07/2014 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Sold 2,500 shares
@ $72, valued at
$180k
Sold 7,500 shares
@ $84.57, valued at
$634.3k
Exercised 2,500 options to buy
@ $4.75, valued at
$11.9k
Exercised 7,500 options to buy
@ $4.75, valued at
$35.6k
|
|
| 03/11/2014 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on QUESTCOR PHARMACEUTICALS INC|
Txns:
| Sold 5,000 shares
@ $65.2128, valued at
$326.1k
|
|
| 09/13/2013 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Bought 8,291 shares
@ $3.899, valued at
$32.3k
Bought 2,922 shares
@ $3.859, valued at
$11.3k
|
|
| 08/21/2013 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Bought 1,487 shares
@ $3.646, valued at
$5.4k
Bought 2,700 shares
@ $3.6585, valued at
$9.9k
|
|
| 07/03/2013 |
4
| FARRELL STEPHEN C (Director) has filed a Form 4 on BIOTIME INC|
Txns:
| Granted 20,000 options to buy
@ $4.13, valued at
$82.6k
|
|
|
|
|